Overview:
Majorly used by the medical community, apheresis is seeing an increase in its application in the control of disease. Though not new to the field of science, therapeutic apheresis is witnessing an increase in scope over the last few years. In fact, each year, a large number of patients, the number going to millions, go through this treatment.
As per Transparency Market Research, the global apheresis equipment market would chart a CAGR of 11.3% from 2012 to 2028 and by the end of this period, the market worth would rise to USD 2.3 bn. It is a notable increase from USD 1.1 bn. in the year 2011.
Some of the factors that are leading to growth in the market are increase in incidence of diabetes and increase in prevalence of chronic diseases. Some of the most significant factors helping the market stay buoyant are outlined below:
- In America, 133 million people suffer from chronic diseases. Percentage wise this comes to 40% of the overall population. Six in every ten people in the region are suffering from a chronic disease and four in every ten are suffering from more than one. This will lead to growth in global apheresis equipment market.
- In 2014, the number of diabetics was a hefty 422 million and the prevalence of this disease in the year for adults aged 18 and above was 8.5%. The prevalence is quite high and rapidly increasing in countries that are considered middle or low income
- Increase in geriatric population is a significant factor driving growth in this market. One in every six people in the world with be old by the year 2050 and some 2 billion people will be falling in the age group of 60 and above by the same year. The pace of ageing would be higher in North America and Europe.
In the past few decades, the medical community all across the world has increasingly engaged in the use of apheresis. In therapeutic apheresis, a patient’s plasma or blood cellular parts are split and removed from the blood and replaced by substitute plasma or substitute blood fluids. The rationale behind apheresis is that the abnormal substances or cells in the patient’s blood are removed through apheresis, thereby leading to cure or control of the disease.
Therapeutic apheresis is not a new application, but its extent and scope has rapidly grown in the last two decades. At present, apheresis is primarily accepted as an acute therapeutic method in a variety of diseases, and millions of patients undergo the treatment every year. Today, apheresis is being evaluated as a treatment option for a wide range of chronic diseases such as rheumatoid arthritis, different forms of cancer, polyneuropathies, multiple sclerosis, and others.
The American Society for Apheresis published an edition of guidelines for the practice of therapeutic apheresis in 2010. All the guidelines mentioned by the Society are based on the review of scientific literature on apheresis. The clinical utility of any mentioned disease in the guidelines is denoted by a category (I – IV). In addition, the quality and the strength of the available clinical evidence of such disease is denoted by standard grade recommendations.
The major market drivers influencing the growth of apheresis equipments business are the rise in demand for plasma and plasma products, improvement in healthcare infrastructure in emerging economies and improvement in the status of reimbursement policies. However, factors such as lack of donor availability and histocompatibility issues, costly therapeutic methods, and lack of highly trained technicians might hamper the growth in demand for apheresis equipments.
TABLE OF CONTENT
Chapter 1 Introduction
1.1 Report Description
1.2 Methodology
1.3 List Of Acronyms
Chapter 2 Executive Summary
Chapter 3 Apheresis Equipment Market Overview
3.1 Introduction
3.2 Therapeutic Apheresis
3.2.1 Guidelines On The Use Of Therapeutic Apheresis In Clinical Practice
3.3 Donor Apheresis
3.4 Market Dynamics
3.4.1 Drivers
3.4.1.1 Increase In Number Of Platelet Donors
3.4.1.2 Growth In The Demand For Plasma
3.4.1.3 Improvement In Healthcare Infrastructure In Emerging Economies
3.4.1.4 Reimbursement Policies
3.4.2 Restraints
3.4.2.1 Expensive Therapy
3.4.2.2 Risks Associated With Apheresis
3.4.2.3 Lack Of Donor Availability & Histocompatibilty
3.4.2.4 Lack Of Highly Trained Professionals
3.4.3 Opportunities
3.4.3.1 Application Of Therapeutic Apheresis In Anti-Aging Treatment
3.5 Porter’s Five Forces Analysis
3.5.1 Bargaining Power Of Buyers
3.5.2 Bargaining Power Of Suppliers
3.5.3 Threat Of New Entrants
3.5.4 Threat Of Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis
3.7 Market Share Analysis, 2011
3.7.1 Market Share Analysis Of Major Market Players In Apheresis Equipment Market, 2011 & 2013E (%)
Chapter 4 Global Apheresis Equipment Market, By Applications
4.1 Introduction
4.1.1 Market Share Analysis Of Apheresis Equipment, By Applications, 2011 & 2018
4.2 Neurological Disorders
4.2.1 Global Apheresis Equipment Market In Neurology: Market Revenues, 2010 – 2018 (USD Million)
4.3 Hematology
4.3.1 Global Apheresis Equipment Market In Hematology: Market Revenues, 2010 – 2018 (USD Million)
4.4 Renal Disorders
4.4.1 Global Apheresis Equipment Market In Renal Disorders: Market Revenues, 2010 – 2018 (USD Million)
4.5 Others
4.5.1 Global Apheresis Equipment In Other Diseases: Market Revenues, 2010 – 2018 (USD Million)
Chapter 5 Apheresis Equipment Market, By Types Of Procedures
5.1 Introduction
5.1.1 Market Share Analysis Of Apheresis Equipment, By Procedures, 2011 & 2018 (%)
5.2 Plasmapheresis
5.2.1 Global Plasmapheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
5.3 Photopheresis
5.3.1 Global Photopheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
5.4 Leukapheresis
5.4.1 Global Leukapheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
5.5 Plateletpheresis
5.5.1 Global Plateletpheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
5.6 LDL Apheresis
5.6.1 Global LDL-Apheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
5.7 Erythrocytapheresis
5.7.1 Global Erythrocytapheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
5.8 Others (Lymphapheresis, Lipidpheresis)
5.8.1 Global Apheresis Equipment In Other Procedures Market Revenues, 2010 – 2018 (USD Million)
Chapter 6 Global Apheresis Machines Market, By Technology
6.1 Introduction
6.1.1 Market Share Analysis Of Technologies Used In Apheresis Machines, 2011 & 2018 (%)
6.2 Centrifugation
6.2.1 Global Centrifugation Technology In Apheresis Machines: Market Revenues, 2010 – 2018 (USD Million)
6.3 Membrane Filtration
6.3.1 Global Membrane Filtration Technology In Apheresis Machines: Market Revenues, 2010 – 2018 (USD Million)
Chapter 7 Global Apheresis Equipment Market, By Geography
7.1 Introduction
7.1.1 Market Share Analysis Of Apheresis Equipment Market, By Geography, 2011 & 2018 (%)
7.2 North America
7.2.1 North America Apheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
7.3 Europe
7.3.1 Europe Apheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Apheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
7.5 Rest Of World
7.5.1 ROW Apheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
Chapter 8 Competitive Landscape
8.1 Introduction
8.2 Major Strategies By Key Players
8.3 Recommendations
Chapter 9 Company Profiles
9.1 Asahi Kasei Kuraray Medical Co., Ltd.
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 SWOT Analysis
9.1.4 Strategic Overview
9.1.5 Recent Developments
9.2 Terumo BCT, Inc.
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 SWOT Analysis
9.2.4 Strategic Overview
9.2.5 Recent Developments
9.3 Fenwal, Inc.
9.3.1 Company Overview
9.3.2 SWOT Analysis
9.3.3 Strategic Overview
9.3.4 Recent Developments
9.4 Haemonetics Corp.
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 SWOT Analysis
9.4.4 Strategic Overview
9.4.5 Recent Developments
9.5 Therakos, Inc.
9.5.1 Company Overview
9.5.2 SWOT Analysis
9.5.3 Strategic Overview
9.5.4 Recent Developments
9.6 B. Braun Melsungen AG
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 SWOT Analysis
9.6.4 Strategic Overview
9.6.5 Recent Developments
9.7 Hemacare Corporation
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Strategic Overview
9.7.4 Recent Developments
LIST OF TABLES
TABLE 1 List Of Acronyms
TABLE 2 Global Apheresis Equipment Market: SNAPSHOT
TABLE 3 Major Therapeutic Uses Of Apheresis
TABLE 4 Guidelines On The Use Of Therapeutic Apheresis In Category I Diseases
TABLE 5 Guidelines On The Use Of Therapeutic Apheresis In Category II Diseases
TABLE 6 Guidelines On The Use Of Therapeutic Apheresis In Category III Diseases
TABLE 7 Guidelines On The Use Of Therapeutic Apheresis In Category IV Diseases
LIST OF FIGURES
FIG. 1 Global Apheresis Equipment Market, By Applications, 2011 (USD Million)
FIG. 2 Global Apheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
FIG. 3 Market Attractiveness Analysis Of Apheresis Equipment, By Applications, 2011
FIG. 4 Market Share Analysis Of Major Market Players In The Apheresis Equipment Market, 2011 & 2013E (%)
FIG. 5 Market Share Analysis Apheresis Equipment, By Applications, 2011 & 2018 (%)
FIG. 6 Global Apheresis Equipment In Market Neurology: Market Revenues, 2010 – 2018 (USD Million)
FIG. 7 Global Apheresis Equipment Market In Hematology: Market Revenues, 2010 – 2018 (USD Million)
FIG. 8 Global Apheresis Equipment Market In Renal Disorders: Market Revenues, 2010 – 2018 (USD Million)
FIG. 9 Global Apheresis Equipment Market In Other Applications: Market Revenues, 2010 – 2018 (USD Million)
FIG. 10 Market Share Analysis Of Apheresis Equipment, By Procedures, 2011 & 2018 (%)
FIG. 11 Global Plasmaphersis Equipment Market Revenues, 2010 – 2018 (USD Million)
FIG. 12 Global Photopheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
FIG. 13 Global Leukapheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
FIG. 14 Global Plateletpheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
FIG. 15 Global LDL-Apheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
FIG. 16 Global Erythrocytapheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
FIG. 17 Global Apheresis Equipment In Other Procedures Market Revenues, 2010 – 2018 (USD Million)
FIG. 18 Market Share Analysis Of Technologies Used In Apheresis Machines, 2011 & 2018 (%)
FIG. 19 Global Centrifugation Technology In Apheresis Machines: Market Revenues, 2010 – 2018 (USD Million)
FIG. 20 Global Membrane Filtration Technology In Apheresis Machines: Market Revenues, 2010 – 2018 (USD Million)
FIG. 21 Market Share Analysis Of Apheresis Equipment Market, By Geography, 2011 & 2018 (%)
FIG. 22 North America Apheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
FIG. 23 Europe Apheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
FIG. 24 Asia Pacific Apheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
FIG. 25 ROW Apheresis Equipment Market Revenues, 2010 – 2018 (USD Million)
FIG. 26 Asahi Kasei Corporation – Healthcare Segment: Net Sales, 2009 – 2011 (USD Million)
FIG. 27 Terumo BCT: Net Sales, 2009 – 2011 (USD Million)
FIG. 28 Haemonetics Corp.: Net Sales, 2009 – 2011 (USD Million)
FIG. 29 B. Braun Melsungen AG: Net Sales, 2009 – 2011 (USD Million)
FIG. 30 Hemacare Corp.: Net Sales, 2009 – 2011 (USD Million)
